Pharma
It will be used to invest in specialised healthcare logistics and financing, among other plans.
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
They seek to identify digital predictive biomarkers of narcolepsy and excessive daytime sleeping.
The grocery chain's healthcare division also announced its first trial, a collaboration with Persephone Biosciences.
RxPass, which will be available to Prime members, will offer generic drugs for common conditions like high blood pressure and anxiety.
The U.K.-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.
Cuban tells MobiHealthNews that MCCPDC is working on adding partnerships with PBMs that "share our mission of cost-plus pricing, transparency and no rebates."
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.